Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$398M |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$286M |
| 4 |
UnitedHealth
UNH
|
+$267M |
| 5 |
Veralto
VLTO
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$730M |
| 2 |
Meta Platforms (Facebook)
META
|
+$674M |
| 3 |
Costco
COST
|
+$635M |
| 4 |
Amazon
AMZN
|
+$528M |
| 5 |
Expedia Group
EXPE
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 11.46% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Zura Bio
ZURA
$497M
| $40.3K | ﹤0.01% |
+9,929
| New | +$49.6K |
|
1802
Sylvamo
SLVM
$1.52B
| $38.6K | ﹤0.01% |
+787
| New | +$36.8K |
|
1803
MGIC Investment
MTG
$6.27B
| $38.2K | ﹤0.01% |
1,981
-21,546
| -92% | -$381K |
|
1804
FIGS
FIGS
$1.59B
| $37.4K | ﹤0.01% |
6,106
+2,383
| +64% | +$15.8K |
|
1805
Mesa Laboratories
MLAB
$539M
| $37.1K | ﹤0.01% |
364
| – | – |
|
|
DNB
1806
DELISTED
Dun & Bradstreet
DNB
| $37K | ﹤0.01% |
3,162
+518
| +20% | +$5.28K |
|
|
LGF.A
1807
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $36.6K | ﹤0.01% |
3,731
+1,907
| +105% | +$17.4K |
|
1808
indie Semiconductor
INDI
$733M
| $36.1K | ﹤0.01% |
4,820
-3,588
| -43% | -$23.4K |
|
1809
Golar LNG
GLNG
$4.95B
| $35.9K | ﹤0.01% |
1,546
| – | – |
|
1810
Orthofix Medical
OFIX
$455M
| $35.2K | ﹤0.01% |
2,415
-2,098
| -46% | -$24.6K |
|
1811
Midland States Bancorp
MSBI
$669M
| $35K | ﹤0.01% |
1,268
| – | – |
|
1812
Amkor Technology
AMKR
$16.1B
| $34.8K | ﹤0.01% |
1,046
-28,988
| -97% | -$762K |
|
1813
TaskUs
TASK
$506M
| $33.4K | ﹤0.01% |
2,642
-9,706
| -79% | -$108K |
|
|
HUT
1814
Hut 8
HUT
$12.4B
| $32.4K | ﹤0.01% |
2,763
+198
| +8% | +$2.11K |
|
|
KLRS
1815
Kalaris Therapeutics
KLRS
$88.7M
| $30.9K | ﹤0.01% |
+1,976
| New | +$77.9K |
|
1816
Editas Medicine
EDIT
$399M
| $30.4K | ﹤0.01% |
3,294
-3,049
| -48% | -$26.8K |
|
1817
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $29.8K | ﹤0.01% |
724
+400
| +123% | +$17.1K |
|
|
CLVR
1818
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $29.5K | ﹤0.01% |
8,442
| – | – |
|
1819
Revolve Group
RVLV
$1.79B
| $29.4K | ﹤0.01% |
1,942
+750
| +63% | +$11.1K |
|
1820
StepStone Group
STEP
$3.48B
| $29.2K | ﹤0.01% |
918
+441
| +92% | +$12.5K |
|
|
GOOS
1821
Canada Goose Holdings
GOOS
$868M
| $29.1K | ﹤0.01% |
2,465
+766
| +45% | +$9.06K |
|
|
ONC
1822
BeOne Medicines Ltd
ONC
$33.8B
| $28.9K | ﹤0.01% |
159
-35
| -18% | -$6.33K |
|
1823
Victory Capital Holdings
VCTR
$6.08B
| $28.1K | ﹤0.01% |
816
+328
| +67% | +$10.5K |
|
|
OLO
1824
DELISTED
Olo Inc
OLO
| $28.1K | ﹤0.01% |
5,414
| – | – |
|
1825
Kforce
KFRC
$983M
| $28.1K | ﹤0.01% |
416
| – | – |
|
Similar funds
Amundi's Q4 2023 Portfolio in Review
As of Q4 2023, Amundi held 2,118 positions worth $222B, up 9.2% from $203B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi's Q4 2023 filing shows 107 new, 857 increased, 762 reduced and 120 closed positions. Its largest new stake was Veralto: 3,549,374 shares worth $276M. The largest sale was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $730M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q4 2023 buy was Veralto: 3,549,374 shares worth $276M.
- Amundi added most to Johnson & Johnson in Q4 2023, an estimated $398M increase.
- Amundi's biggest Q4 2023 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $730M.
- Amundi fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
- Amundi's ten largest holdings make up 23% of its $222B portfolio in Q4 2023.
- Amundi opened 107 new positions and closed 120 in Q4 2023.
- Amundi's portfolio value rose 9.2% quarter-over-quarter to $222B.
Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.